Theraflu Sinus

Quick links to important sections

Theraflu Sinus

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Theraflu Sinus

Quick Facts

Property Description
Active Ingredients Acetaminophen, Phenylephrine HCl
Form Powder for oral solution (hot liquid) or tablet
Pharmacological Class Analgesic and Decongestant combination
Common Use Relief of sinus pain and nasal congestion
Origin Synthetic

What Type of Medicine is Theraflu Sinus? (Definition and Classification)

Theraflu Sinus is classified as an over-the-counter (OTC) combination medication designed to treat symptoms associated with sinus pressure. It falls into the pharmacological class of a dual-action agent, combining a pain reliever with a nasal decongestant. Medications containing acetaminophen and phenylephrine are used to temporarily relieve congestion and sinus pressure caused by the common cold, allergies, or other breathing illnesses. A distinguishing feature of the Theraflu brand is its powder form for hot liquid solution, a characteristic preferred by some patients seeking the soothing warmth associated with treating cold and flu symptoms.


What are the Active Ingredients in Theraflu Sinus? (Composition and Origin)

Theraflu Sinus includes two primary synthetic active ingredients: acetaminophen and phenylephrine HCl. Acetaminophen serves as the analgesic and fever reducer, while Phenylephrine HCl acts as the decongestant. Regarding the decongestant component, oral phenylephrine is clinically recognized for its ability to reduce swelling of nasal membranes. This indicates the ingredient is used for its intended purpose of helping to clear the nasal passages and ease pressure.


What is the Primary Goal of Theraflu Sinus? (General Therapeutic Purpose)

The primary goal of Theraflu Sinus is to alleviate the painful pressure and discomfort caused by clogged and swollen sinus passages. By combining an analgesic and a decongestant, the product provides effective symptomatic relief. For instance, it can be used to manage a typical scenario where a person experiences a sinus headache accompanied by persistent nasal blockage. The anticipated therapeutic outcome is improved comfort and better airflow, addressing the core complaints of a sinus episode.

Regulatory References

  1. U.S. National Library of Medicine
  2. as reported in research

What side effects are possible with Theraflu Sinus?

Possible Side Effects and Safety Information

Safety information for this combination medication (Acetaminophen and Phenylephrine HCl) is established in regulatory documents that classify potential adverse effects and define constraints for its use. The documented safety profile reflects the combined actions of its analgesic and decongestant components.

Documented Adverse Reactions by System and Frequency

Official labeling classifies reactions by physiological system and frequency. Common reactions often involve Nervous System Disorders (e.g., headache, dizziness, insomnia, nervousness) and Gastrointestinal Disorders (e.g., nausea, vomiting). Less frequent effects, often classified as uncommon or rare, may involve Cardiac Disorders (palpitations, tachycardia) and Vascular Disorders (increased blood pressure). Serious rare events are also documented, including effects on the Hepatobiliary System and Skin and Subcutaneous Tissue.

Serious Adverse Reactions and Constraints

The most critical constraint concerns the risk of severe Hepatotoxicity (liver damage) associated with the acetaminophen component. This risk is primarily dose-dependent, mandating strict adherence to the maximum daily dose to prevent cumulative overdose, a principle highlighted in FDA safety warnings. Other serious, though rare, adverse reactions include severe cutaneous adverse reactions (SCARs) and potentially severe allergic responses.

Safety constraints are explicitly defined for individuals with certain pre-existing conditions. Official labeling advises caution for patients with severe hepatic impairment, severe hypertension, coronary artery disease, and thyroid disease. Furthermore, the product must not be used with or within two weeks of stopping a Monoamine Oxidase Inhibitor (MAOI), as this combination is documented to carry a serious risk of hypertensive crisis.

Overdose and Emergency Response

Overdose: When to Seek Immediate Medical Help

Theraflu Sinus contains acetaminophen, a drug associated with a risk of severe liver damage, liver transplantation, or death if taken in excess. Overdose is possible when the maximum daily dosage of acetaminophen (4,000 mg) is exceeded, when the product is used concurrently with other medicines containing acetaminophen, or when combined with chronic, heavy alcohol consumption (three or more alcoholic drinks daily).

Overdose Symptoms and Manifestations

Initial signs of an acetaminophen overdose may be subtle and include nausea, vomiting, upper stomach pain, loss of appetite, sweating, weakness, or confusion. Symptoms may take several days to appear. Delayed or severe presentations can include yellowing of the skin or eyes (jaundice), dark urine, clay-colored stools, and signs of severe liver damage. Fatal, severe skin reactions, such as skin reddening, blisters, or a widespread rash, have also been reported in association with acetaminophen use.

When to Seek Emergency Attention

Immediate medical attention is critical in all cases of suspected overdose, even if no symptoms are immediately noticeable. If you or someone else may have taken more than the recommended dose, contact a Poison Control Center or seek emergency medical attention right away. Medical help is also required immediately if a severe skin reaction develops.

Therapeutic Uses of Theraflu Sinus

What Theraflu Sinus Treats: Main Uses and Benefits

Theraflu Sinus is commonly used for the temporary relief of symptoms associated with acute episodes, generally addressing symptoms related to systemic discomfort and congestion. The product is primarily applied across domains where additional symptomatic support is needed, helping to manage symptom clusters that may become intense or disruptive.

Supportive Relief for Acute Discomfort

This medication offers short-term symptomatic assistance during periods of increased discomfort, supporting patients when conditions are characterized by periods of heightened symptoms. It is used in situations involving symptoms related to physical discomfort, supporting the patient to cope more steadily with difficult episodes. As a supportive measure, it contributes to improved comfort during symptomatic periods.

Assistance for Functional Stability

Theraflu Sinus is considered relevant in clinical scenarios where symptoms create noticeable physiological strain or discomfort, requiring supportive relief. It provides assistance with symptoms related to heightened physiological activity, which may assist with maintaining functional stability when symptoms become more noticeable.


Quick Fact: Support for Systemic Discomfort (This category of product plays a role in managing the overall symptom load when symptoms become more noticeable.)

Regulatory References

  1. NIH DailyMed overview on cold/flu combination products

Eligibility and Restrictions for Use

Who Can and Cannot Use Theraflu Sinus?

This eligibility profile is based strictly on the official regulatory documentation for products containing the combination of Acetaminophen and Phenylephrine HCl, defining which populations are authorized, restricted, or prohibited from use.


Populations Contraindicated (Must Not Use)

Use is absolutely contraindicated for several groups based on the active ingredients:

  • Children under 12 years of age are ineligible for this product.
  • Individuals with known hypersensitivity or allergy to Acetaminophen or Phenylephrine.
  • Patients currently taking or who have taken a prescription Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.

Conditional Eligibility (Ask a Health Professional Before Use)

Official labeling defines restricted use for individuals with specific pre-existing health conditions or physiological states:

  • Chronic Conditions: People with heart disease, high blood pressure, liver disease, diabetes, or thyroid disease are directed to seek professional advice.
  • Reproductive Status: Individuals who are pregnant or breast-feeding are instructed to consult a health professional.
  • Comorbidities: Use is restricted for patients with trouble urinating (such as from an enlarged prostate) or those with a history of chronic alcohol use (three or more drinks per day).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Theraflu Sinus (Acetaminophen and Phenylephrine HCl) establishes specific restrictions and cautions concerning co-administration with other substances.


Contraindicated Combinations

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated, including drugs such as isocarboxazid, phenelzine, and linezolid. This is due to the documented risk of hypertensive crisis from the additive effects of phenylephrine. Furthermore, Theraflu Sinus is contraindicated with any other medicine containing acetaminophen to prevent severe liver damage from exceeding the maximum daily dose.

Interaction-Related Restrictions and Cautions

Category Official Regulatory Statement
Timing Restriction Must not be used for at least 14 days after discontinuing MAOI therapy.
Hepatotoxic Risk Chronic, excessive alcohol consumption (three or more drinks daily) is officially documented to increase the risk of severe liver damage when combined with the acetaminophen component.
Exposure Modification Acetaminophen may increase the anticoagulant effect of Warfarin and other Coumarin derivatives, which may require caution during co-use.
Pharmacodynamic Risk Combination with sedatives or tranquilizers may result in additive Central Nervous System (CNS) depression, as documented by regulatory agencies.

The overall interaction structure is defined by prohibitions against combinations that cause severe sympathomimetic reinforcement (MAOIs) and restrictions concerning substances that increase the risk of hepatotoxicity (alcohol, other acetaminophen products).

Mechanism of Action

Cyclooxygenase Enzyme Modulation

This domain involves Acetaminophen, which acts primarily within the central nervous system. It engages mechanisms that modulate the activity of cyclooxygenase (COX) enzymes, particularly in the brain. Modifying these early molecular steps reduces the production of prostaglandins, which are signaling molecules involved in thermoregulation and nociception. This cascade results in altered signaling for thermoregulation and reduced prostaglandin-mediated sensitization of nociceptors.


Adrenergic Receptor Agonism

This mechanism is mediated by a sympathomimetic agent like Phenylephrine. It acts within domains involving adrenergic receptor-mediated signaling, specifically by stimulating alpha-adrenergic receptors on blood vessels, such as those in the nasal mucosa. This activation initiates a signaling sequence resulting in vasoconstriction. The physiological consequence is localized vasoconstriction, which results in decreased plasma extravasation in the nasal mucosa.


Histamine H1 Receptor Blockade

The antihistamine component, such as Pheniramine Maleate, engages mechanisms that regulate overactive processes driven by histamine. It works by blocking the action of histamine at H1 receptors on certain cells. This receptor antagonism suppresses the effects of histamine release, which is a key pathway associated with mast cell activation and increased vascular permeability. This results in the inhibition of histamine-mediated cellular responses in the upper respiratory system.

Dosage and Administration Information

How to Use Theraflu Sinus: Official Administration Guidelines

Theraflu Sinus, a product available as a powder-for-oral-solution, is administered according to standard guidelines. The information below details the procedural steps, dosing, and frequency for use.


Administration Scope

Feature Guideline
Route of Administration Oral (as a hot liquid drink)
Dosing Schedule One packet (one dose)
Frequency Every 4 hours, while symptoms persist
Maximum Daily Dose Do not take more than 6 packets in 24 hours, unless directed by a doctor.

Preparation and Age Rules

Feature Guideline
Preparation Dissolve the contents of one packet into 8 oz. of hot water; sip while hot. The entire drink must be consumed within 10–15 minutes.
Age 12 Years and Over One packet per dose.
Age Under 12 Years Do not use.

Official Procedural Steps

  1. Preparation: Dissolve the contents of one packet into 8 oz. of hot water.
  2. Administration: Sip the liquid while it is hot, ensuring the entire drink is consumed within 10–15 minutes.
  3. Dosing: Repeat this procedure every 4 hours while symptoms persist, but do not use more than directed.

This medication is taken on an as-needed basis to manage symptoms, adhering to the 4-hour interval between doses and the maximum 24-hour limit. Complete information regarding use is available on the product labeling.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Theraflu Sinus


Evidence for Relief of Systemic Pain and Discomfort

This section will summarize the structure of the research evidence, including Randomized Controlled Trials (RCTs) and Systematic Reviews, that have examined the analgesic component's role in addressing pain and fever associated with cold and flu-like symptoms.

The research examined patient-reported outcomes describing perceived discomfort related to cold symptoms. These studies generally consist of short-term RCTs that compare the compound to a placebo and included adults experiencing cold or flu-like symptoms. Research on the analgesic component includes a large volume of trials, contributing to the understanding of symptom patterns during periods of heightened symptom activity.

Findings describe patterns observed in the studies where measurements indicated changes in patient-scored pain severity and data showed patterns related to temperature changes. However, evidence is limited when exploring the consistency of reported findings for changes in certain other associated symptoms, such as a sore throat or general feeling of illness (malaise).


Evidence for Nasal Congestion and Sinus Pressure

This section will detail the types of clinical trials and regulatory reviews that assessed the oral decongestant component's influence on subjective patient scores for nasal stuffiness and objective measures of nasal airflow in adults.

The decongestant component was evaluated in Randomized Controlled Trials (RCTs) designed to explore its activity concerning nasal blockage and congestion. Research examined patient-reported outcomes describing perceived discomfort related to nasal stuffiness, primarily including adults with cold symptoms or seasonal allergies.

Recent high-level regulatory reviews and multiple RCTs reported that the oral component, when administered at the approved dose, did not achieve an effect distinguishable from placebo when measuring changes in nasal congestion severity. The findings from this research indicate that the existing data do not provide supportive evidence for this component's activity in relieving nasal symptoms. This regulatory finding is a major limitation frame for the research base concerning oral phenylephrine.


What Remains Unclear or Uncertain in the Research

This final section will synthesize the major research limitations documented by regulators and scientific reviews. While the analgesic component's action on pain is generally recognized, findings were mixed regarding the component's influence on secondary cold symptoms. Evidence quality varies across studies, and the research highlights what is known — and what is still uncertain, confirming that observed changes are typically short-term, and data for certain groups remain insufficient.

Frequently Asked Questions (FAQ)

Common questions about Theraflu Sinus (FAQ)


Q: How long does it typically take for Theraflu Sinus to start working?

A: Official documents for the decongestant component describe a quick onset of action, typically occurring within minutes for this class of product. The expected onset of effect for the oral solution is often described as occurring shortly after consumption.


Q: What should I do if I miss a dose of Theraflu Sinus?

A: Regulatory guidance describes a pattern where a missed dose is taken as soon as remembered. If it is almost time for the next scheduled dose, the pattern described is to skip the missed dose and continue the regular schedule. It is cautioned not to take a double dose to make up for a missed one.


Q: How long can Theraflu Sinus be used before needing to stop?

A: Regulatory guidelines recommend using the product only for a short time for self-treatment. Regulatory labeling contains the direction to stop use and consult a healthcare professional if pain or nasal congestion lasts more than 7 days.


Q: Can Theraflu Sinus be taken with a pain reliever like ibuprofen or acetaminophen?

A: Official warnings strictly contraindicate the use of this product with any other drug containing acetaminophen due to the risk of severe liver damage. Regulatory labeling includes a caution that consulting a health professional is necessary before combining it with other non-acetaminophen drugs like ibuprofen.


Q: Is it safe to drive after taking Theraflu Sinus?

A: Official drug labeling warns that the product may cause drowsiness or dizziness. Official labeling includes the warning to be careful when driving a motor vehicle or operating machinery while using the product.


Q: Are there studies that examine the effect of Theraflu Sinus on blood pressure?

A: Regulatory safety information lists increased blood pressure as a potential adverse reaction of the decongestant component, and advises caution for those with existing high blood pressure. This indicates that cardiovascular effects are a documented area of safety concern within the regulatory profile.


Q: Does Theraflu Sinus affect sleep?

A: Official drug labeling lists insomnia (difficulty sleeping) and nervousness as common potential side effects associated with the active ingredients, which may affect sleep patterns.


Q: What does official labeling say about use during pregnancy?

A: The official Drug Facts label includes the statement to consult a health professional before use if the individual is pregnant or breast-feeding. This is standard guidance for many over-the-counter medications.


Q: What is the maximum number of days it is recommended to use Theraflu Sinus?

A: The regulatory guidelines contain the information to stop use and consult a professional if pain or nasal congestion gets worse or lasts more than 7 days. This time limit applies to self-treatment.


Q: Is Theraflu Sinus used for all types of sinus issues?

A: Official labeling specifies that the product is for the temporary relief of symptoms such as nasal and sinus congestion and sinus headache due to the common cold. It does not claim coverage for all types of sinus conditions.


Q: What is the difference between Theraflu Sinus and regular Theraflu?

A: The primary difference is defined by the specific combination of active ingredients used. Theraflu Sinus primarily combines a pain reliever and a decongestant, while other 'Regular Theraflu' or 'Cold & Flu' formulas may contain additional ingredients, such as a cough suppressant or a sedating antihistamine.


Q: Can Theraflu Sinus be used to help with a headache?

A: Yes, official labeling explicitly lists the temporary relief of headache and minor aches and pains as one of the intended uses of the product, due to the presence of the analgesic component (acetaminophen).


Q: Are there any common food or drink interactions with Theraflu Sinus?

A: Official warnings include a specific caution regarding chronic, excessive alcohol consumption due to increased risk of liver damage. Regulatory labeling does not typically list specific interactions with common non-alcoholic foods or drinks.


Q: Does Theraflu Sinus interact with caffeine?

A: Regulatory-derived guidance suggests that caffeine and the decongestant component may have additive central nervous system (CNS) stimulant effects. This could potentially worsen side effects like nervousness or trouble sleeping.


Q: Why is Theraflu Sinus sometimes associated with feeling restless?

A: Official safety information lists nervousness and restlessness as documented potential side effects associated with the use of the decongestant component in the product.


Q: What is the risk of dependence or withdrawal from Theraflu Sinus?

A: The active ingredients are not classified as controlled substances. However, regulatory-derived information notes the risk of psychological dependence is associated with the misuse of the analgesic component (acetaminophen) in high doses.


Q: Is there a special way to take the hot liquid powder formulation?

A: Official directions describe the required preparation steps, stating the product is dissolved in 8 oz. of hot water and is consumed while hot, within 10–15 minutes of preparation to ensure proper use according to the drug label.


Q: Can Theraflu Sinus be used for allergies?

A: Regulatory documents state that one of the intended uses is for symptoms due to the common cold or allergic rhinitis (allergies). However, recent regulatory reviews have indicated that the oral decongestant component may not be considered reliably effective for this use.


Q: Does Theraflu Sinus contain aspirin?

A: No. The product's official labeling names the active ingredients as Acetaminophen and Phenylephrine HCl. Aspirin (acetylsalicylic acid) is not listed as an active ingredient.


Q: Are there official documents that describe long-term side effects of Theraflu Sinus?

A: Official guidelines limit the use of this product to a short time (not more than 7 days) for self-treatment. Due to this short-term recommendation, the safety information primarily focuses on acute and short-term adverse reactions.


Q: Can Theraflu Sinus affect the effectiveness of birth control?

A: Regulatory-derived guidance suggests that the active ingredients, acetaminophen and phenylephrine, are not typically reported to reduce the effectiveness of hormonal birth control pills. Information often includes the statement to consult a health professional before co-use.


Q: What are the ingredients in Theraflu Sinus that relieve pain?

A: Official labeling explicitly names Acetaminophen as the ingredient that serves as the pain reliever and fever reducer.


Q: Why do some people experience dry mouth with Theraflu Sinus?

A: Although not listed as a common effect of this specific two-ingredient formula, dry mouth is a documented potential adverse reaction of the decongestant component when included in similar cold preparations.


Q: Is Theraflu Sinus gluten-free?

A: Drug labeling is not required by regulation to certify products as 'gluten-free'. To confirm the absence of gluten-containing grains (wheat, barley, rye), checking the inactive ingredients or contacting the manufacturer is indicated.


Q: How long do the effects of Theraflu Sinus last?

A: The drug is intended to be taken every four hours while symptoms persist, which suggests the manufacturer's expected duration of symptomatic relief aligns with this 4-hour dosing interval.


Q: What is the role of the decongestant ingredient in Theraflu Sinus?

A: The official role of the decongestant component, Phenylephrine HCl, is to act as a nasal decongestant to help temporarily relieve nasal and sinus congestion by constricting blood vessels in the nasal passages.


Q: Are there different Theraflu Sinus formulas (e.g., day vs. night)?

A: Regulatory databases list multiple Theraflu products, including formulas designated as 'Daytime' and 'Nighttime' versions. The difference is primarily defined by the presence of an additional ingredient, such as a sleep-inducing antihistamine, in the Nighttime version.


Q: Is Theraflu Sinus safe for someone who has had a heart condition?

A: Official labeling includes the statement to consult a health professional before use if the individual has heart disease or a history of high blood pressure, as use may be restricted for those with a history of cardiovascular conditions.


Q: Does Theraflu Sinus interact with herbal supplements?

A: Official warnings include a general instruction that consulting a professional about all other medications, including vitamins and herbs, is recommended, particularly because some herbal supplements may have sympathomimetic effects.


Q: Is Theraflu Sinus non-addictive?

A: The active ingredients are not classified as controlled substances. However, regulatory-derived information notes the risk of psychological dependence is associated with the misuse of the analgesic component (acetaminophen) in high doses.


Q: Can Theraflu Sinus be taken if I am using an SSRI antidepressant?

A: Regulatory guidance suggests a potential for interaction between sympathomimetic decongestants and drugs like SSRI antidepressants. Guidance on interactions generally includes the statement that consulting a health professional before combining these types of medications is necessary.


Q: What is the recommended use for Theraflu Sinus according to regulatory bodies?

A: The regulatory use is the temporary relief of cold and flu symptoms including minor aches and pains, headache, and nasal/sinus congestion in adults and children 12 years and over.


Q: Is it possible to have an allergic reaction to Theraflu Sinus?

A: Official drug labeling includes an Allergy Alert, stating that acetaminophen may cause severe skin reactions. Official labeling states the user should stop use and seek medical help if symptoms like skin reddening, blisters, or rash occur.


Q: Can Theraflu Sinus cause stomach upset?

A: Official labeling classifies gastrointestinal disorders as documented potential adverse reactions. These include common effects such as nausea, vomiting, and mild stomach pain/upset.


Q: What distinguishes the sinus relief from the cold and flu relief formulas?

A: The distinction is defined by the combination of active ingredients used. Sinus relief formulas typically focus on the analgesic and decongestant components, while cold and flu formulas often add ingredients like a cough suppressant or a sedating antihistamine.

How should Theraflu Sinus be stored and disposed of?

How to Store and Dispose of Theraflu Sinus?

This section details the officially documented storage and disposal requirements for this medication.


Official Storage Requirements

Requirement Specific Condition
Temperature Store at controlled room temperature, between 20 C and 25 C (68 F and 77 F).
Protection Must be protected from heat and moisture. Liquid forms should be kept tightly closed and not refrigerated.
Safety Must be kept out of reach of children.

Disposal Instructions

Official guidelines state that unused or expired medication should be disposed of by following specific instructions on the drug labeling or by utilizing a drug take-back program. If neither is available, mix the product with an undesirable substance (e.g., kitty litter) and place it in a sealed container for household trash. Do not flush the medication down the toilet or sink unless the label explicitly instructs you to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Theraflu Sinus found in:

A-Z Index: